Table II.
Comparison of Clinical Outcome of Embryo Transfer Between Test (EmbryoGlue®) and Control (G-1™ver 3) Groups in Patients With Recurrent Implantation Failures and Different Indications of Infertility
Test group | Control group | |||||
---|---|---|---|---|---|---|
PR | IR | MP | PR | IR | MP | |
Recurrent implantation failures (≥2 cycles) | 43/128 (33.6) | 65/407 (16)* | 14/43 (32.6) | 38/147 (25.9) | 48/436 (11) | 9/38 (23.7) |
Male factors | 60/181 (33.1) | 85(556) (15.3) | 12/60 (20) | 51/165 (30.9) | 69/494 (14) | 7/51 (13.7) |
Tubal factors | 19/50 (38)* | 31/151 (20.5)* | 5/19 (26. 3) | 9/48 (18.8) | 12/135 (8.9) | 2/9 (22.7) |
Ovarian disorders | 18/71 (25.4) | 25/218 (11.5) | 4/18 (22.2) | 19/67 (28.4) | 25/197 (12.7) | 4/19 (21/1) |
Idiopathics | 12/30 (40) | 19/82 (23.2) | 4/12 (33) | 14/32 (43.8) | 15/97 (15.5) | 1/14 (7) |
Endometriosis | 4/13 (30.8) | 4/32 (12.5) | 0/4 (0) | 0/4 (0) | 0/14 (0) | 0/0 (0) |
Multiple factors | 12/67 (17.9) | 17/176 (9.7) | 3/12 (25) | 23/80 (28.8) | 29/224 (12.9) | 5/23 (21) |
Uterine factors | 5/5 (100) | 5/15 (33) | 0/5 (0) | 1/2 (50) | 1/5 (20) | 0/1 (0) |
Note. Values in parentheses are percentage; PR: Pregnancy rate; IR: Implantation rate; MP: Multiple pregnancy rate.*p < 0.05.